California Senate happy to allow groups to distribute condoms to prison inmates

The California Senate on Thursday voted 22-16 to approve a bill (AB 1677) that would allow not-for-profit or public health organizations to distribute devices - such as condoms or dental dams - that can protect against sexually transmitted infections to the state's 162,000 prison inmates, the AP/San Jose Mercury News reports (Young, AP/San Jose Mercury News, 8/24).

Supporters of the bill, by Assembly member Paul Koretz (D), say it would help curb the spread of HIV and other sexually transmitted infections in the state.

The federal government estimates that about 30% of federal male prison inmates engage in sex acts with other male inmates.

However, the state corrections department does not track the number of inmates caught or punished for engaging in such acts.

Opponents of the bill say it would encourage inmates to engage in sexual intercourse in prisons, which is illegal in the state (Kaiser Daily HIV/AIDS Report, 6/3/05).

The bill now goes to Gov. Arnold Schwarzenegger (R) for consideration (Rau, Los Angeles Times, 8/25).

According to Schwarzenegger's office, the governor has not taken a position on the bill (Reuters, 8/24).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New two-dose HIV vaccine strategy shows promise for stronger immune response